AF
CCXI

Amalgamated Financial’s ChemoCentryx, Inc. CCXI Stock Holding History

Amalgamated Financial’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$167K Buy
+6,669
New +$187K ﹤0.01% 1967

Other funds holding CCXI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Amalgamated Financial's CCXI Position: Q1 2022 in Review

Amalgamated Financial opened a new position in ChemoCentryx, Inc. (CCXI) in Q1 2022: 6,669 shares worth $167K. The stake represents ﹤0.01% of the portfolio and ranks #1967 among its holdings.

176 funds tracked by Wall St. Rank hold CCXI as of Q1 2022.

  • Amalgamated Financial held 6,669 shares of ChemoCentryx, Inc. worth $167K as of Q1 2022.
  • ChemoCentryx, Inc. was a new Amalgamated Financial position in Q1 2022.
  • ChemoCentryx, Inc. made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #1967 holding.
  • 176 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.